Taking together, we establish a PIR‐NIK‐NFκB2‐FAS survival signaling transduction pathway and suggest that PIR is an important survival factor functioning to promote CRC malignancy by inhibiting FAS‐based apoptosis in multiple mechanisms. Here, PIR is linked to colorectal carcinoma.